Koyi Hirsh

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ANTICANCER RESEARCH. 2023;43(2):669-673

Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks.

Koyi H; Wilander E
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022;130(4):513-521

The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.

Björn N; Jakobsen I; Udagawa C; Brandén E; Koyi H; Lewensohn R; De Petris L; Zembutsu H; Gréen H
Article: ARCHIVES OF REHABILITATION RESEARCH AND CLINICAL TRANSLATION. 2022;4(1):100177

Swallowing Function in COVID-19 Patients After Invasive Mechanical Ventilation.

Lindh MG; Mattsson G; Koyi H; Johansson MB; Razmi R; Palm A
Article: RESPIRATORY MEDICINE. 2021;186:106527

Mesothelioma in immigrants from Turkey: Genes have a minor role.

Metintas S; Metintas M; Ak G; Hillerdal G; Koyi H
Article: ERJ OPEN RESEARCH. 2021;7(2):173-2021

Swallowing dysfunction in patients hospitalised due to a COPD exacerbation.

Gonzalez Lindh M; Janson C; Blom Johansson M; Jonsson M; Mälberg E; Allansson E; Holm C; Jennische M; Koyi H
Article: INTERNATIONAL JOURNAL OF CANCER. 2021;148(1):238-251

A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.

Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Article: LUNG CANCER. 2020;147:106-114

Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing.

Svedberg A; Björn N; Sigurgeirsson B; Pradhananga S; Brandén E; Koyi H; Lewensohn R; De Petris L; Apellániz-Ruiz M; Rodríguez-Antona C; Lundeberg J; Gréen H
Article: NPJ SYSTEMS BIOLOGY AND APPLICATIONS. 2020;6(1):25

Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.

Björn N; Badam TVS; Spalinskas R; Brandén E; Koyi H; Lewensohn R; De Petris L; Lubovac-Pilav Z; Sahlén P; Lundeberg J; Gustafsson M; Gréen H
Article: JOURNAL OF THORACIC DISEASE. 2020;12(7):3524-3528

Intrabronchial stents in heterogenous emphysema: a highly selected material followed 5 years.

Hillerdal G; Koyi H
Article: PHARMACOGENOMICS JOURNAL. 2020;20(2):179-191

Genes and variants in hematopoiesis-related pathways are associated with gemcitabine/carboplatin-induced thrombocytopenia.

Björn N; Sigurgeirsson B; Svedberg A; Pradhananga S; Brandén E; Koyi H; Lewensohn R; de Petris L; Apellániz-Ruiz M; Rodríguez-Antona C; Lundeberg J; Gréen H
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(8):1704-1709

Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.

Svedberg A; Vikingsson S; Vikström A; Hornstra N; Kentson M; Branden E; Koyi H; Bergman B; Gréen H
Article: ERJ OPEN RESEARCH. 2019;5(3):81-2019

Subjective swallowing symptoms and related risk factors in COPD.

Gonzalez Lindh M; Malinovschi A; Brandén E; Janson C; Ställberg B; Bröms K; Blom Johansson M; Lisspers K; Koyi H
Article: JOURNAL OF THORACIC ONCOLOGY. 2019;14(4):628-640

Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.

Edlund K; Madjar K; Mattsson JSM; Djureinovic D; Lindskog C; Brunnström H; Koyi H; Brandén E; Jirström K; Pontén F; Rahnenführer J; Micke P; Hengstler JG
Article: LUNG CANCER. 2019;130:50-58

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.

La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Article: SCIENTIFIC REPORTS. 2019;9(1):5207

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.

Karlsson A; Cirenajwis H; Ericson-Lindquist K; Brunnström H; Reuterswärd C; Jönsson M; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Micke P; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(7):1741-1752

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
Article: LUNG CANCER. 2018;124:45-52

Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression.

Hydbring P; De Petris L; Zhang Y; Brandén E; Koyi H; Novak M; Kanter L; Hååg P; Hurley J; Tadigotla V; Zhu B; Skog J; Viktorsson K; Ekman S; Lewensohn R
Article: ANTICANCER RESEARCH. 2018;38(6):3341-3346

Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.

Koyi H; Brandén E; Kasim I; Wilander E
Article: BMJ OPEN. 2018;8(4):e019933

A protocol for a prospective observational study using chest and thumb ECG: transient ECG assessment in stroke evaluation (TEASE) in Sweden.

Magnusson P; Koyi H; Mattsson G
Article: CARDIOLOGY JOURNAL. 2018;25(3):363-370

Outcome of implantable loop recorder evaluation.

Magnusson PM; Olszowka M; Wallhagen M; Koyi H
Article: MODERN PATHOLOGY. 2017;30(7):964-977

Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.

Grinberg M; Djureinovic D; Brunnström HR; Mattsson JS; Edlund K; Hengstler JG; La Fleur L; Ekman S; Koyi H; Branden E; Ståhle E; Jirström K; Tracy DK; Pontén F; Botling J; Rahnenführer J; Micke P
Article: INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 2017;12:331-337

Prevalence of swallowing dysfunction screened in Swedish cohort of COPD patients.

Gonzalez Lindh M; Blom Johansson M; Jennische M; Koyi H
Article: ACTA ONCOLOGICA. 2016;55(11):1344-1348

Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survival.

Koyi H; Hillerdal G; Andersson O; Högberg H; Brandén E
Article: ANTICANCER RESEARCH. 2016;36(10):5397-5402

Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice.

Koyi H; Hillerdal G; Kölbeck K-G; Brodin D; Liv P; Brandén E
Article: BMC CANCER. 2016;16:603

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.

Mattsson JSM; Brunnström H; Jabs V; Edlund K; Jirström K; Mindus S; la Fleur L; Pontén F; Karlsson MG; Karlsson C; Koyi H; Brandén E; Botling J; Helenius G; Micke P; Svensson MA
Article: JCI INSIGHT. 2016;1(10):e86837

Profiling cancer testis antigens in non-small-cell lung cancer.

Djureinovic D; Hallström BM; Horie M; Mattsson JSM; La Fleur L; Fagerberg L; Brunnström H; Lindskog C; Madjar K; Rahnenführer J; Ekman S; Ståhle E; Koyi H; Brandén E; Edlund K; Hengstler JG; Lambe M; Saito A; Botling J; Pontén F; Uhlén M; Micke P
Article: CLINICAL CANCER RESEARCH. 2016;22(2):366-373

Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities.

Gréen H; Hasmats J; Kupershmidt I; Edsgärd D; de Petris L; Lewensohn R; Blackhall F; Vikingsson S; Besse B; Lindgren A; Brandén E; Koyi H; Peterson C; Lundeberg J
Article: JOURNAL OF THORACIC DISEASE. 2015;7(12):2226-2233

Biopsy testing in an inoperable, non-small cell lung cancer population-a retrospective, real-life study in Sweden.

Koyi H; Johansson L; From J; Nyrén S
Article: JOURNAL OF CHROMATOGRAPHY A. 2015;1422:34-42

Application of graphitic sorbent for online microextraction of drugs in human plasma samples.

Iadaresta F; Crescenzi C; Amini A; Colmsjö A; Koyi H; Abdel-Rehim M
Article: LUNG CANCER INTERNATIONAL. 2015;2015:317868-6

Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden.

Koyi H; Hillerdal G; Andersson O; Kölbeck K-G; Liv P; Brandén E
Article: ANTICANCER RESEARCH. 2015;35(7):3979-3985

Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome.

Sandelin M; Berglund A; Sundström M; Micke P; Ekman S; Bergqvist M; Bergström S; Koyi H; Brandén E; Janson C; Botling J
Article: LAKARTIDNINGEN. 2015;112:DEYE

[Waiting time in lung cancer care. Patient guides provided faster flow].

Holgersson G; Bergqvist M; Koyi H; Berglund A; Lambe M; Bergström S
Article: MEDICAL ONCOLOGY. 2015;32(4):129

A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.

Holgersson G; Bergström S; Harmenberg J; Ringbom M; Klockare M; Jerling M; Ekman S; Lundström KL; Koyi H; Brandén E; Larsson O; Bergqvist M
Article: ONCOLOGIST. 2015;20(4):365

Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one center.

Branden E; Hillerdal G; Kolbeck K; Koyi H
Article: LAKARTIDNINGEN. 2015;112:DCCP

[Screening for lung cancer in Sweden requires large resources].

Koyi H; Hillerdal G
Article: ANNALS OF THORACIC MEDICINE. 2014;9(3):149-153

Computer tomography-guided core biopsies in a county hospital in Sweden: Complication rate and diagnostic yield.

Brandén E; Wallgren S; Högberg H; Koyi H
Article: LAKARTIDNINGEN. 2012;109(5):208-209

[Screening for lung cancer can save lives, according to US study. Too early for mass screening--but refer smokers to CT on broad indications].

Koyi H; Hillerdal G
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(1):131-137

Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer.

De Petris L; Brandén E; Herrmann R; Sanchez BC; Koyi H; Linderholm B; Lewensohn R; Linder S; Lehtiö J
Article: LAKARTIDNINGEN. 2010;107(51-52):3286-3287

[Indwelling pleural catheters give symptom relief in malignant pleuritis].

Ukale V; Koyi H
Article: JOURNAL OF THORACIC ONCOLOGY. 2010;5(10):1706-1713

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.

Pirker R; Herth FJF; Kerr KM; Filipits M; Taron M; Gandara D; Hirsch FR; Grunenwald D; Popper H; Smit E; Dietel M; Marchetti A; Manegold C; Schirmacher P; Thomas M; Rosell R; Cappuzzo F; Stahel R; European EGFR Workshop Group
Article: LUNG CANCER. 2009;63(3):410-417

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Article: LUNG CANCER. 2008;60(1):113-124

Symptoms and problems with functioning among women and men with inoperable lung cancer--a longitudinal study.

Lövgren M; Tishelman C; Sprangers M; Koyi H; Hamberg K
Article: INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 2007;2(4):643-650

Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema.

Brandén E; Gnarpe J; Hillerdal G; Orre L; Sköld CM; Löfdahl M; Koyi H; Tornling G
Article: RESPIRATORY MEDICINE. 2005;99(1):20-26

Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.

Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(11-12):811-816

Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection.

Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Article: LUNG CANCER. 2002;37(2):137-142

The 'reservoir' of undetected bronchial carcinomas in the general population.

Koyi H; Hillerdal G; Brandén E; Nordesjö L-O
Article: LUNG CANCER. 2002;36(1):9-14

A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits.

Koyi H; Hillerdal G; Brandén E
Article: LUNG CANCER. 2002;35(1):53-57

Patient's and doctors' delays in the diagnosis of chest tumors.

Koyi H; Hillerdal G; Brandén E
Article: APMIS. 2001;109(9):572-580

An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study.

Koyi H; Brandén E; Gnarpe J; Gnarpe H; Steen B
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2000;14(5):407-408

Intratracheal metastasis from malignant melanoma.

Koyi H; Brandén E
Article: APMIS. 1999;107(9):828-832

Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study.

Koyi H; Brandén E; Gnarpe J; Gnarpe H; Arnholm B; Hillerdal G
Article: EUROPEAN RESPIRATORY JOURNAL. 1997;10(12):2711-2715

Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.

Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E
Visa fler

Alla övriga publikationer

Letter: ERJ OPEN RESEARCH. 2021;7(4):515-2021

Swallowing dysfunction in patients hospitalised due to a COPD exacerbation.

Gonzalez Lindh M; Janson C; Koyi H
Letter: ACTA ONCOLOGICA. 2020;59(1):28-32

Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers.

Ramqvist T; Ortiz-Villalon C; Brandén E; Koyi H; de Petris L; Wagenius G; Brodin O; Reuterswärd C; Dalianis T; Jönsson M; Staaf J; Lewensohn R; Planck M
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2019;14(10):s982

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) - Experiences from Clinical Practice - Sweden

Koyi H; Isaksson J; Vikstrom A; Ohman R; Xanthoulis P; Rosberg A; Branden E
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2019;14(10):s913-s914

Systemic Hyperinflammation Is a Strong Independent Predictor of Early Mortality in Advanced NSCLC

Isaksson J; Willen L; Branden E; Koyi H; Gagatek S; Berglund A; Micke P; Botling J
Meeting abstract: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2019;405:124

Brain metastases manifestaion of advanced non-small cell lung cancer (NSCLC)

Koyi H; Branden E; Daham K
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2019;14(10):S784

Analysis of Human Papilloma Viruses (HPV) and Human Polyoma Viruses (HPyV) in Lung Cancer from Swedish Never-Smokers

Ramqvist T; Ortiz-Villalon C; Branden E; Koyi H; De Petris L; Wagenius G; Brodin O; Reutersward C; Dalianis T; Jonsson M; Staaf J; Lewensohn R; Planck M
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2019;14(10):S568-S569

Lung Cancer in Never-Smokers: A Nationwide Population Based Mapping of Targetable Alterations

Salomonsson A; Jonsson M; Reutersward C; Behndig A; Bergman B; Botling J; Branden E; Brunnstrom H; De Petris L; Hussein A; Johansson M; Koyi H; Lundstrom KL; Lewensohn R; Monsef N; Ortiz-Villalon C; Patthey A; Vikstrom A; Wagenius G; Staaf J; Planck M
Meeting abstract: EUROPEAN RESPIRATORY JOURNAL. 2019;54:pa4228

Critical handling errors with dry-powder, metered dose and soft-mist inhaler devices in an observational COPD study

Sulku J; Jansoon C; Melhus H; Koyi H; Hammarlund-Udenaes M; Stallberg B; Broms K; Malinovschi A; Hogman M; Lisspers K; Nielsen E
Meeting abstract: CHEST. 2019;155(4):95A

THE IMPACT OF COPD ON ICU ADMISSION

Koyi H; Xanthoulis P; Gonzalez M; Sulku J
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2018;13(10):s687

The Cost of Lung Cancer in the County of Gavleborg - Sweden

Koyi H; Isaksson J; Melas N; Branden E
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2018;13(10):S431-S432

A Nation-Wide Population-Based Mapping of Targetable Alterations in Smoking-Independent Lung Cancer

Salomonsson A; Patthey A; Reutersward C; Jonsson M; Botling J; Brunnstrom H; Hussein A; Monsef N; Ortiz-Villalon C; Bergman B; De Petris L; Lamberg K; Viltstrom A; Wagenius G; Behndig A; Branden E; Johansson M; Koyi H; Staaf J; Planck M
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(11):S1819

Scavenger Receptor MARCO Defines a Targetable Tumor-Associated Macrophage Subset in Lung Cancer

La Fleur L; Boura V; Berglund A; Mattsson J; Djureinovic D; Persson J; Brunnstrom H; Isaksson J; Branden E; Koyi H; Micke P; Karlsson M; Botling J
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(11):S1820

Cancer Testis Antigens and Mutational Load in Relation to the Immune Landscape of Non-Small Cell Lung Cancer

Backman M; Kurppa P; Djureinovic D; La Fleur L; Persson J; Mattsson J; Botling J; Branden E; Koyi H; Ponten F; Micke P
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(11):S1565

Treatment of Elderly (70 years or older) with Lung Cancer: A Five Year Material in Clinical Practice from Gavle Hospital - Sweden

Koyi H; Melas N
Review: ACTA ONCOLOGICA. 2017;56(10):1249-1257

Implementation of lung cancer CT screening in the Nordic countries.

Pedersen JH; Sørensen JB; Saghir Z; Fløtten Ø; Brustugun OT; Ashraf H; Strand T-E; Friesland S; Koyi H; Ek L; Nyrén S; Bergman P; Jekunen A; Nieminen E-M; Gudbjartsson T
Meeting abstract: CANCER RESEARCH. 2017;77:5028

Whole exome sequencing and genetic association of gemcitabine/carboplatin induced thrombocytopenia in non-small cell lung cancer patients

Bjorn N; Svedberg A; Sigurgeirsson B; Pradhananga S; Branden E; Koyi H; Lewensohn R; De Petris L; Rodriguez-Antona C; Apellaniz-Ruiz M; Lundeberg J; Green H
Meeting abstract: CANCER RESEARCH. 2017;77:5026

Association to drug-induced leukopenia using whole-exome sequencing of non-small cell lung cancer patients on gemcitabine/carboplatin regimen

Svedberg A; Sigurgeirsson B; Bjorn N; Pradhananga S; Branden E; Koyi H; Lewensohn R; De Petris L; Rodriguez-Antona C; Apellaniz-Ruiz M; Lundeberg J; Green H
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(1):S669

Non-Small Cell Lung Cancer in Octogenarians: Real-Life Clinical Practice; Characteristics, Therapy and Survival

Koyi H; Hillerdal G; Kolbeck KG; Brodin D; Branden E
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(1):s526-s527

Mutation Profiling by Targeted Next Generation Sequencing of an Unselected NSCLC Cohort

La Fleur L; Falk-Sorqvist E; Smeds P; Sundstrom M; Mattsson J; Branden E; Koyi H; Isaksson J; Brunnstrom H; Sandelin M; Lamberg K; Landelius P; Nilsson M; Micke P; Moens L; Botling J
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(1):s499-s500

Establishing Reflex NGS Testing in NSCLC in a Regional Network of County Hospitals in Central Sweden

Isaksson J; Willen L; La Fleur L; Mindus S; Sundstrom M; Branden E; Koyi H; Sandelin M; Lamberg K; Micke P; Moens L; Lundberg G; Botling J
Meeting abstract: EUROPEAN RESPIRATORY JOURNAL. 2016;48:pa3945

Incorrect inhaler technique is common in patients with COPD - Data from the TIE study

Sulku J; Hogman M; Stallberg B; Malinovschi A; Lisspers K; Nielsen E; Melhus H; Koyi H; Hammarlund-Udenaes M
Meeting abstract: EUROPEAN RESPIRATORY JOURNAL. 2016;48:pa1013

The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD - Results from the TIE-study

Ellingsen J; Hedenstrom H; Hogman M; Lisspers K; Stallberg B; Christer J; Andrei M; Koyi H; Branden E; Broms K; Thornadtsson A; Lindh MG; Sulku J; Bendrik R; Lundkvist J
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2011;47:S124

Plasma Metabolomics in Non-small-cell Lung Cancer

De Petris L; Forshed J; Antti H; Branden E; Koyi H; Johnsson A; Lewensohn R; Lehtio J
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(15):e18039

Pemetrexed plus gemcitabine versus gemcitabine plus carboplatin in patients with advanced nanoperable NSCLC: A randomized phase II study

Hillerdal GN; Koyi H; Branden E; Kolbeck K
Meeting abstract: BLOOD. 2007;110(11):4085

Darbepoetin alfa administered every 3 weeks is effective in correcting hemoglobin and reducing transfusion requirements in anemic patients with hematological malignancies receiving chemotherapy: A retrospective observational study reflecting real-world clinical practice in Europe

Coiffier B; Coeffic D; Strohbach F; Schweigert M; Koyi H; Hamilton L; Suto T
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2007;2(8):S356-S357

Mass spectrometry profiling of low molecular weight platelet Proteome for the detection of lung cancer specific biomarkers

De Petris L; Pernemalm M; Branden E; Koyi H; Forshed J; Sundelin B; Lewensohn R; Lehtio J
Meeting abstract: LUNG CANCER. 2005;49:S177

Prior malignancies in patients diagnosed with lung cancer

Brandén E; Koyi H
Letter: LAKARTIDNINGEN. 2001;98(32-33):3453

[Smoking cessation or lung cancer screening--an artificial antagonism].

Hillerdal G; Koyi H; Brandén E
Visa fler

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Solna, Karolinska Institutet, 2001

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI